Innate Pharma SA
Innate Pharma SA
09/02/2026 | Press release | Distributed by Public on 09/01/2026 23:01
Innate pharma to participate in the H.C. Wainwright 28th annual global investment conference
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in a fireside chat and one-on-one investor meetings at the following conference:
H.C. Wainwright 28th Annual Global Investment Conference
- Dates: September 14-16, 2026
- Location: New York, United States
Fireside chat:
- Date: September 14, 2026
- Time: 4:30 PM EDT / 10:30 PM CEST
- Webcast: Access the webcast
The link to access the live webcast of the fireside chat will also be available on the Events page of the Investors section of Innate Pharma's website. A replay will be available following the event.
Innate Pharma SA published this content on September 02, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 02, 2026 at 05:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]